Base de lotion purifiante

1. INCI et CAS

INCI: Salicylic Acid · CAS: 69-72-7

2. Rôle dans la formule

Salicylic Acid is listed as a hydroxy-acid ingredient in this development reference. The recorded formula also lists Squalane and Zinc PCA. Review the complete formula and evidence for its intended cosmetic use; ingredient presence does not establish acne treatment.

3. Niveaux d'emploi typiques (repère de formulation)

• This guide records a component allocation of 0.5% w/w.

Pre-dissolve in a suitable solvent or a hot water phase as the TDS allows. Confirm EU, US and China limits before filing.

4. Sources réglementaires et conformité mondiale

• This note is supplied for formulation development; it is not approval of the purchased material or completed cosmetic; This is not authorization of a product as sold.

5. Sécurité et évaluation des risques

This entry provides guidance for cosmetic use only; this reference is not approval for drug use or OTC marketing with patch response and finished-product stability still to be verified.

6. Stabilité et conditionnement

Store the bulk in a closed container in a cool, shaded place; if oxidation risk calls for it, review a pump or airless format; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Salicylic Acid in a direction centered on low-level BHA clarifying.

• The formulation note provides no basis for claims of drug action or cure, or a product certification outside the supporting records.
• This guide to Salicylic Acid offers no support for skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI et CAS

INCI: Zinc PCA · CAS: 15454-75-8

2. Rôle dans la formule

Zinc PCA is listed as a conditioning ingredient in this development reference. The recorded formula also lists Squalane and Salicylic Acid. Review application feel and conditioning performance in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The component's reference allocation is recorded at 0.6% w/w.

Dissolve in water. Check compatibility with anionic thickeners.

4. Sources réglementaires et conformité mondiale

• This entry is a formulation-development reference; it is not a product authorization or an approval of supplier grade; It does not establish approval for the finished cosmetic.

5. Sécurité et évaluation des risques

Use the stated level as reference guidance for cosmetic formulation; it is not evidence of drug approval or OTC authorization and the final formula should undergo patch and stability assessment.

6. Stabilité et conditionnement

Store the bulk in a closed container in a cool, shaded place; if the formula is oxidation-sensitive, an airless or pump format may be considered; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Zinc PCA as part of a cosmetic direction focused on zinc PCA balance.

• This cosmetic guide does not substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The formulation record for Zinc PCA does not support whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane is listed as an emollient in this development reference. The recorded formula also lists Zinc PCA and Salicylic Acid. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• This entry shows a reference allocation of 2% w/w.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Sources réglementaires et conformité mondiale

• This listing is guidance for formula development; neither the supplied ingredient grade nor the final product is approved by it; No authorization for the final cosmetic is implied.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; no drug approval or OTC status is conferred by this entry so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Keep bulk supplies closed, cool, and protected from sunlight; take oxidation sensitivity into account when selecting the final pack; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• The development record does not establish therapeutic results, cure claims, or unverified certification claims.
• This Squalane listing does not demonstrate a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.